DFI Brings Industrial-Grade Edge AI to Scale at COMPUTEX 2026
Rugged Edge AI platforms deliver reliable, cost-efficient real-world deployment across critical industries TAIPEI, June 1, 2026 /PRNewswire/ -- DFI will showcase its industrial-grade Edge AI platforms at COMPUTEX 2026, held June 2–5, 2026, at Taipei...
Pudu Robotics and Shenzhen CTID Co. Ltd Launch the World's First Full-Scenario Robot-Serviced Hotel Project
A landmark project at the Shenzhen-Zhongshan Link will bring embodied AI into every stage of the guest experience. SHENZHEN, China, June 1, 2026 /PRNewswire/ -- Pudu Robotics, a global leader in commercial service robotics, and Shenzhen Culture...
Haisco Announces Licensing and Research Collaboration Agreement with Lilly to Develop Innovative Medicines Across Multiple Therapeutic Areas
SILICON VALLEY, Calif. and BEIJING, June 1, 2026 /PRNewswire/ -- On May 29, 2026, Haisco Pharmaceutical Group Co., Ltd. ("Haisco") (Ticker Code: 002653) announced a licensing and research collaboration with Eli Lilly and Company ("Lilly") to develop...
Bakery China 2026 Concludes Successfully, Advancing Global Integration and Innovation in the Bakery Industry
SHANGHAI, June 1, 2026 /PRNewswire/ -- Bakery China 2026, the 28th edition of the exhibition, concluded successfully on May 23 at the National Exhibition and Convention Center (NECC) in Shanghai, reinforcing its role as a major global platform for...
Hanmi Signs Licensing Deal with Lilly for sonefpeglutide (LAPSGLP-2 analog)
Lilly licenses Hanmi's sonefpeglutide (LAPSGLP-2 analog) for multiple indications SEOUL, South Korea, June 1, 2026 /PRNewswire/ -- Hanmi Pharm. Co., Ltd. ("Hanmi") today announced that they have entered into a license agreement for the development,...
China International ITS Industry Expo 2026 Concludes, Showcasing China's Strength Through Cutting-Edge Capabilities
XIAMEN, China, June 1, 2026 /PRNewswire/ -- On May 15, 2026, the three-day CITSE 2026 successfully concluded. Co-organized by China Intelligent Transportation Systems Association and Xiamen C&E Group, this year's CITSE 2026 was themed "Focus on...
Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab for First-Line Treatment of PD-L1-Positive NSCLC Published in The Lancet
CHENGDU, China, May 31, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company", 6990.HK) announced today that the results of the Phase III clinical study OptiTROP-Lung05, evaluating the company's trophoblast...
The Results of Phase III OptiTROP-Lung05 Study of Sacituzumab Tirumotecan (sac-TMT) Presented as an ASCO Oral Presentation and Simultaneously Published in The Lancet
CHENGDU, China, May 30, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company", 6990.HK) announced today that at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, the results of the Phase...
Kelun-Biotech Presents Pivotal Phase II Data for Lunbotinib Fumarate (A400/EP0031) in RET Fusion-Positive NSCLC at 2026 ASCO
CHENGDU, China, May 30, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company", 6990.HK) announced that at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago, USA, results from the...
LEIFRAS Co., Ltd. Achieves 45% Growth in After-School Day Care Network, Expanding from 20 to 29 Locations Nationwide
Expanding Developmental Support Services Through Organic Growth and Strategic M&A TOKYO, May 29, 2026 /PRNewswire/ -- LEIFRAS Co., Ltd. (Nasdaq: LFS) (the "Company" or "Leifras"), a sports and social business company dedicated to youth sports...